Sinclair Pharma

Sinclair Pharma Overview

Company Headquarters: London, UK

Founded: 1971

Workforce: 1,000

Company Working: Sinclair Pharma is a global healthcare company engaged in the development, manufacture, and distribution of pharmaceutical products. Other medical offerings of the company include aesthetics and cosmetic products. It has a portfolio of differentiated complementary aesthetics technologies with a focus on collagen stimulation. The company constitutes a huge network of international distributors throughout the world. Sinclair Pharma operates as a subsidiary of Huadong Medicine Co., Ltd.(China). The company has a strong presence in Europe, as well as the US, Brazil, and South Korea

Strategy

Sinclair Pharma aims to focus on major aesthetic markets such as the US, the UK, and Brazil by providing quality products and generating maximum revenue from these markets. Moreover, it also focuses on internal development capabilities, which would be concentrated on utilizing both the current portfolio and new development potential. The company plans to collaborate with different physicians and clinics to create awareness about its products in the market.

Company Snapshot

$5,430.4M

Revenue

1,000

Employees

1971

Founded

London, UK

Headquarters

SWOT Analysis

Strengths

Strong distribution network
Collaborations with physicians and clinics
The company is present in all major markets
Quality products
Skilled workforce

Weaknesses

Limited geographic presence
Depended on the aesthetics segment for revenue generation

Opportunities

Strategic collaborations and partnerships
Geographical expansion through collaborations and mergers and acquisitions
New product launches

Threats

Stringent government regulations
Tough market competition
Extensive regulations

Key Developments

Date	Approach	Development
August 2015	Partnership	Sinclair Pharma partnered with John Bannon Ltd to supply its aesthetic range in Ireland.
–	Acquisition	Sinclair Pharma was acquired by Huadong Medicine Co., Ltd. With this, the company expanded its aesthetic products portfolio.
–	Product Launch	Sinclair Pharma launched Silhouette InstaLift in the market. It offers dual benefits of an instant facelift and volumization for both men and women.
–	Agreement	Sinclair Pharma and Thermigen entered into a strategic distribution agreement for Silhouette InstaLift in the US.
May 2021	Product Launch	Sinclair Pharma (UK) launched the facial filler MaiLi, which contains hyaluronic acid (HA). Premium hyaluronic acid (HA) is used in the newest generation of dermal fillers, MaiLi, to deliver results that are long-lasting and seem natural. While keeping your natural expression and movement, this strong dermal filler provides your skin extra suppleness, volume, and longevity
March 2020	Agreement	Sinclair Pharma (UK) announced the license agreement for MaiLi, a premium innovative facial hyaluronic acid (HA) range with lidocaine. MaiLi technology has been developed by Kylane Laboratories, a Swiss R&D medtech company driven by an expert team with an extensive track record in the HA field. Thus, with this move, Sinclair Pharma aims to expand its foothold in the dermal fillers market.
February 2020	Agreement	Sinclair Pharma (UK) announced the completion of a transaction in which Swiss-based Galderma Laboratories, L.P. acquired the European distribution rights to Sculptra (poly-I-Iactic acid).

Product Offering

Sinclair Pharma
- Dermal Filler

Financial Performance

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.